InsiderTrades

Form 4 for TXG 10x Genomics, Inc.

Accepted 2021-09-03 00:00:00 ET · period of report 2021-09-01 · accession 0001209191-21-054900 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2021-09-03 2021-09-01 TXG McAnear Justin J. CFO M - OptEx $5.04 +10.0K 49.1K +26% +$50.4K
DM 2021-09-03 2021-09-01 TXG McAnear Justin J. CFO S - Sale+OE $177.49 -10.0K 39.1K -20% -$1.77M
D 2021-09-03 2021-09-01 TXG McAnear Justin J. CFO M - OptEx $0.00 -10.0K 390.2K -2% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2021-09-01 M A 10,000 $5.04 49,100 D — —
2 Common Class A Common Stock 2021-09-01 S D 374 $174.87 48,726 D — — (F2) This transaction was executed in multiple trades at prices ranging from $174.20 to $175.15. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
3 Common Class A Common Stock 2021-09-01 S D 1,139 $175.95 47,587 D — — (F3) This transaction was executed in multiple trades at prices ranging from $175.34 to $176.285. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
4 Common Class A Common Stock 2021-09-01 S D 2,200 $177.00 45,387 D — — (F4) This transaction was executed in multiple trades at prices ranging from $176.39 to $177.355. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
5 Common Class A Common Stock 2021-09-01 S D 4,747 $177.87 40,640 D — — (F5) This transaction was executed in multiple trades at prices ranging from $177.41 to $178.36. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
6 Common Class A Common Stock 2021-09-01 S D 1,540 $178.80 39,100 D — — (F6) This transaction was executed in multiple trades at prices ranging from $178.41 to $179.22. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
7 Derivative Stock Option (right to buy) 2021-09-01 M D 10,000 $0.00 390,159 D $5.04 · — to 2028-11-02 10,000 Class A Common Stock (F7) This option, originally for 600,000 shares, of which 209,841 shares have been exercised, vested as to one-fourth of the shares on October 8, 2019 and one forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.